FIT Biotech

FIT Biotech is a biotechnology company based in Tampere, Finland, with a focus on DNA vaccines and gene therapy.

Founded in 1995, the company utilizes its patented GTU® (Gene Transport Unit) technology to develop DNA-based therapeutic and preventive applications, particularly targeting infectious diseases and immunotherapy. The company's primary offerings include GTU-based DNA vaccines and related gene therapy or immunotherapy applications. FIT Biotech is actively involved in developing proprietary products for various health challenges, including HIV, tuberculosis, cancer, and autoimmune diseases. Notable projects include a therapeutic HIV vaccine that has successfully completed Phase II clinical trials and work on an anti-Ebola vaccine. The company collaborates with organizations like Icosagen and Ichor Medical Systems on various vaccine and infectious disease initiatives.